Wendler J, Lewis RI, Kutilina A, Knott M, Isbell LK, Valk E, Borchmann P, Heger J-M, Illerhaus G, Schorb E. Pre-phase treatment with rituximab and high-dose methotrexate to re-evaluate eligibility for intensive induction treatment of frail patients with central nervous system lymphoma. haematol [Internet]. 2020Sep.10 [cited 2025Feb.1];. Available from: https://haematologica.org/article/view/11907